Fundraising FoxHemoshear Therapeutics
Charlottesville, US · Founded 2020 · Delaware corporation
Find your way into Hemoshear Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
414 people can intro you to Brian
Ask Douglas Mayers to introduce you to Brian M. Campbell
You →Douglas · together at US Navy Reserves →Brian
Sign up to find every way you can get introduced to Hemoshear Therapeutics
- Your email: who you already know at Hemoshear Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Hemoshear Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Hemoshear Therapeutics was founded in 2020 by Brian R. Wamhoff and Brett R. Blackman.
BR
Brian R. WamhoffCo-founder
BR
Brett R. BlackmanCo-founder
AH
Aric HolsingerExecutive
JC
James C. PowersExecutive
BM
Brian M. CampbellExecutiveBrian M. Campbell is an Executive Officer and Director at Hemoshear Therapeutics, a biopharmaceutical company focused on gene therapy and rare disease treatments.
NE
Nicole E. HastingsExecutive
KM
Kathleen M. MettersNamed on SEC filing
WT
W. Thompson, Jr.Named on SEC filing
HT
H. Thomas Watkins IIINamed on SEC filing
BA
Brian A. JohnsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$55.1M disclosed across 7 rounds · 2013–2023
▶$3.5MraisedNov 2023 · 4 investors · BiotechnologyRule 506(b)
▶$3.5MraisedNov 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael InnesExecutive Officer
- David FriedmanDirector
- Patrick HornExecutive Officer
- Brian A JohnsExecutive Officer
- John TiltonDirector
- H. Thomas Watkins IIIDirector
- John L Brooks IIIDirector
- Kathleen M MettersDirector
- Aric HolsingerExecutive Officer
- Brian WarmhoffExecutive Officer, Director
- Robert J GouldDirector
- Offering amount
- $8M
- Amount sold
- $3.5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$43.1MraisedFeb 2021 · 17 investors · Other Health CareRule 506(b)
▶$43.1MraisedFeb 2021 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian WamhoffExecutive Officer
- Robert J. GouldDirector
- Kathleen M. MettersDirector
- W. Thompson, Jr.Executive Officer
- H. Thomas Watkins IIIDirector
- Brian A. JohnsExecutive Officer
- John TiltonDirector
- David FriedmanDirector
- James C. PowersExecutive Officer, Director
- Aric R. HolsingerExecutive Officer
- John L. BrooksDirector
- Offering amount
- $48.1M
- Amount sold
- $43.1M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.3MraisedFeb 2020 · 4 investors · BiotechnologyRule 506(b)
▶$2.3MraisedFeb 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark HayesExecutive Officer
- Sandra Rojas-CaroExecutive Officer
- Brian A. JohnsExecutive Officer
- William McIlwaine Thompson, Jr.Executive Officer
- H. Thomas Watkins, IIIDirector
- James C. PowersExecutive Officer, Director
- Robert J. GouldDirector
- John L. Brooks, IIIDirector
- Brian R. WamhoffExecutive Officer
- Reginald F. WoodsDirector
- Aric HolsingerExecutive Officer
- Kathleen M. MettersDirector
- Offering amount
- $4M
- Amount sold
- $2.3M
- First sale
- Feb 2020
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$200KraisedAug 2018 · 1 investors · BiotechnologyRule 506(b)
▶$200KraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John L. Brooks, IIIDirector
- Robert GouldDirector
- Aric HolsingerExecutive Officer
- Brian R. WamhoffExecutive Officer
- James C. PowersExecutive Officer, Director
- Reginald F. WoodsDirector
- Mehmood A. KhanDirector
- H. Thomas Watkins, IIIDirector
- Offering amount
- $200K
- Amount sold
- $200K
- First sale
- Jul 2018
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$800KraisedJun 2017 · 5 investors · BiotechnologyRule 506(b)
▶$800KraisedJun 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John L. Brooks, IIIDirector
- Mehmood A. KhanDirector
- Brian R. WamhoffExecutive Officer
- Robert GouldDirector
- Reginald F. WoodsDirector
- H. Thomas WatkinsDirector
- James C. PowersExecutive Officer, Director
- Aric HolsingerExecutive Officer
- Offering amount
- $5M
- Amount sold
- $800K
- First sale
- May 2017
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$2.6MraisedApr 2017 · 26 investors · BiotechnologyRule 506(b)
▶$2.6MraisedApr 2017 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian R. WamhoffExecutive Officer
- Mehmood A. KhanDirector
- John L. Brooks, IIIDirector
- Aric HolsingerExecutive Officer
- Richard O. WhiteExecutive Officer
- James C. PowersExecutive Officer, Director
- Robert GouldDirector
- H. Thomas WatkinsDirector
- Reginald F. WoodsDirector
- Offering amount
- $20M
- Amount sold
- $2.6M
- Minimum investment
- $250K
- First sale
- Jan 2016
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$2.5MraisedJan 2014 · 24 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJan 2014 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brett R. BlackmanExecutive Officer, Director
- James C. PowersExecutive Officer, Director
- John L. Brooks, IIIDirector
- Brian M. CampbellExecutive Officer, Director
- Frederick W. K. BrownDirector
- Nicole E. HastingsExecutive Officer
- Jonathan M. SackierDirector
- Richard O. WhiteExecutive Officer
- Brian WamhoffExecutive Officer, Director
- Mehmood A. KhanDirector
- W. McIlwaine Thompson, Jr.Director
- Vincent AurentzExecutive Officer
- Reginald F. WoodsDirector
- Offering amount
- $4M
- Amount sold
- $2.5M
- Minimum investment
- $250K
- First sale
- Oct 2013
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Hemoshear Therapeutics?
- Hemoshear Therapeutics was founded by Brian R. Wamhoff, Brett R. Blackman in 2020.
- How much funding has Hemoshear Therapeutics raised?
- Hemoshear Therapeutics has disclosed $55.1M raised across 7 rounds.
- Where is Hemoshear Therapeutics headquartered?
- Hemoshear Therapeutics is headquartered in Charlottesville, US.